The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients
Open accessAbstract
Introduction: suPAR is the soluble form of the urokinase plasminogen activator receptor (uPAR), which is expressed in various immunologically active cells. High suPAR serum concentrations are suggested to reflect the activation of the immune system in circumstances of inflammation and infection, and have been associated with increased mortality in different populations of non-intensive care patients. In this study we sequentially analyzed suPAR serum concentrations within the first week of intensive care in a large cohort of well characterized intensive care unit (ICU) patients, in order to investigate potential regulatory mechanisms and evaluate the prognostic significance in critically ill patients. Methods: A total of 273 patients (197 with sepsis, 76 without sepsis) were studied prospectively upon admission to the medical intensive care unit (ICU), on Day 3 and Day 7, and compared to 43 healthy controls. Clinical data, various laboratory parameters as well as investigational inflammatory cytokine profiles were assessed. Patients were followed for approximately one year. Results: Upon admission to the ICU suPAR serum concentrations were elevated in critically ill patients as compared with healthy controls. In sepsis patients suPAR levels were higher than in non-sepsis patients (with or without systemic inflammatory response syndrome (SIRS)). During the first week after admission to the ICU serum suPAR concentrations remained stably elevated. suPAR serum concentrations measured upon admission were closely and independently correlated to various laboratory parameters, specifically biomarkers of inflammation (tumor necrosis factor (TNF), C-reactive protein (CRP)), hepatic and renal dysfunction. High suPAR levels at admission and at Day 3 were a strong independent predictor for both ICU and long-term mortality in critically ill patients. Conclusions: In sepsis and non-sepsis patients suPAR serum concentrations are increased upon admission to the ICU, likely reflecting the activation state of the immune system, and remain stably elevated in the initial course of treatment. Low suPAR levels are a positive predictor of ICU- and overall survival in critically ill patients, including sepsis and non-sepsis patients. Aside from its value as a promising new prognostic biomarker, both experimental and clinical studies are required in order to understand the specific effects and regulatory mechanisms of suPAR in SIRS and sepsis, and may reveal new therapeutic options.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
uPAR: a versatile signalling orchestrator
Blasi, F., & Carmeliet, P. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm977 · Cited by 1,223
suPAR: The Molecular Crystal Ball
Thunø, M., Macho, B., & Eugen-Olsen, J. (2009) · Disease Markers · doi:10.1155/2009/504294 · Cited by 548
Eugen‐Olsen, J., Andersen, O., Linneberg, A., Ladelund, S., Hansen, T. W., Langkilde, A., Petersen, J., Pielak, T., Møller, L. N., Jeppesen, J., et al. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02252.x · Cited by 383
Sidenius, N., & Blasi, F. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1023099415940 · Cited by 368
Kofoed, K., Andersen, O., Kronborg, G., Tvede, M., Petersen, J., Eugen-Olsen, J., & Larsen, K. (2007) · Critical Care · doi:10.1186/cc5723 · Cited by 298
Cancer invasion and tissue remodeling‐cooperation of protease systems and cell types
DANØ, K., RØMER, J., NIELSEN, B. S., BJØRN, S., PYKE, C., RYGAARD, J., & LUND, L. R. (1999) · APMIS · doi:10.1111/j.1699-0463.1999.tb01534.x · Cited by 291
The association of endothelial cell signaling, severity of illness, and organ dysfunction in sepsis
Shapiro, N. I., Schuetz, P., Yano, K., Sorasaki, M., Parikh, S. M., Jones, A. E., Trzeciak, S., Ngo, L., & Aird, W. C. (2010) · Critical Care · doi:10.1186/cc9290 · Cited by 268
uPAR-induced cell adhesion and migration: vitronectin provides the key
Madsen, C. D., Ferraris, G. M. S., Andolfo, A., Cunningham, O., & Sidenius, N. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200612058 · Cited by 232
Koch, A., Gressner, O. A., Sanson, E., Tacke, F., & Trautwein, C. (2009) · Critical Care · doi:10.1186/cc7925 · Cited by 168
Self-citation
Cited by
Backes, Y., van der Sluijs, K. F., Mackie, D. P., Tacke, F., Koch, A., Tenhunen, J. J., & Schultz, M. J. (2012) · Intensive Care Medicine · doi:10.1007/s00134-012-2613-1 · Cited by 268
Self-citationKahles, F., Meyer, C., Möllmann, J., Diebold, S., Findeisen, H. M., Lebherz, C., Trautwein, C., Koch, A., Tacke, F., Marx, N., et al. (2014) · Diabetes · doi:10.2337/db14-0100 · Cited by 212
Self-citationGLP-1 Levels Predict Mortality in Patients with Critical Illness as Well as End-Stage Renal Disease
Lebherz, C., Schlieper, G., Möllmann, J., Kahles, F., Schwarz, M., Brünsing, J., Dimkovic, N., Koch, A., Trautwein, C., Flöge, J., et al. (2017) · The American Journal of Medicine · doi:10.1016/j.amjmed.2017.03.010 · Cited by 65
Self-citationReisinger, A. C., Niedrist, T., Posch, F., Hatzl, S., Hackl, G., Prattes, J., Schilcher, G., Meißl, A.-M., Raggam, R. B., Herrmann, M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-96352-1 · Cited by 19
Rolles, B., Gorgulho, J., Tometten, M., Roderburg, C., Vieri, M., Abels, A., Vucur, M., Heymann, F., Tacke, F., Brümmendorf, T. H., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.729207 · Cited by 12
Self-citation
Metadata
- Authors
- Koch, A., Voigt, S., Kruschinski, C., Sanson, E., Dückers, H., Horn, A., Yagmur, E., Zimmermann, H., Trautwein, C., & Tacke, F.
- Venue
- Critical Care
- Published
- 2011-02-16
- Volume
- 15
- Issue
- 1
- Pages
- R63-R63
- ISSN
- 1364-8535 (ISSN-L)
- OpenAlex
- W2132828093
- Cited by
- 280
- References
- 21
- FWCI
- 19.45
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients. https://app.cochat.ai/papers/10.1186/cc10037
- The paper
- Koch, A., Voigt, S., Kruschinski, C., Sanson, E., Dückers, H., Horn, A., Yagmur, E., Zimmermann, H., Trautwein, C., & Tacke, F. (2011). Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients. Critical Care. https://doi.org/10.1186/cc10037
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.